Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Share buy-back program
-
Movellus Advanced Clocking IP Selected for QuickLogic’s Strategic Radiation Hardened FPGA Program
-
Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results
-
Ubitium tapes out universal processor to end embedded computing complexity crisis
-
Panda Express® Brings Back Its Hottest Collab Yet: Dynamite Sweet & Sour Chicken Goes Nationwide With Buldak®
-
Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
-
Skyryse Announces Universal, Emergency Autoland Capability Coming to SkyOS™, Bringing Automated Safe Landings to Both Helicopters and Airplanes
-
Bitfarms Expands Leadership Team with Seasoned U.S. Industry Experts to Support HPC/AI Infrastructure Development
-
Panda Express® Brings Back Its Hottest Collab Yet: Dynamite Sweet & Sour Chicken Goes Nationwide With Buldak®
-
Constellation Software Inc. Announces Results for the Fourth Quarter and Year Ended December 31, 2025 and Declares Quarterly Dividend
-
AOI Receives First Volume Order of 1.6T Data Center Transceivers from Major Hyperscale Customer
-
Aecon Utilities expands U.S. electrical utility services capabilities with acquisition of Duna Services and an interest in KNX Utility Services
-
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
-
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
-
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinic
-
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
-
ISC Selected to Build and Operate the Future International Registry for Mining, Agriculture and Construction Equipment
-
Nobel Identifies New Mineralized Porphyry Copper System, Cuprita Project, Chile
-
PyroGenesis Announces $1 Million Non-Brokered Private Placement
-
Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region
-
B2BROKER and Centroid Strengthen Collaboration to Enhance B2TRADER Liquidity and Risk Capabilities
-
Siris Agrees to Acquire a Majority Stake in TAKKION from Apollo Funds
-
Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
-
Zefiro Founder Updates Shareholders on British Columbia Securities Commission Ruling Ahead of Shareholder Vote
-
Nasdaq to launch equity token design, putting issuers at the center of tokenization
-
3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results
-
HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD
-
Osisko Development Announces Proceeds of $24.9 Million From Warrant Exercise
-
Omni-Lite Industries Canada Announces Leadership Transition To Accelerate Its Transformation Into A High-Performance Serial Acquiror of Niche Aerospace and Defense Businesses and Assets
-
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
-
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
-
Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan
-
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
-
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
-
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
-
Fairfield Opens Leasing for The Penstone Apartments and Townhomes in Walpole, Mass
-
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
MEXC Foundation Co-Hosts International Women's Day Workshop in Sydney
-
MEXC Foundation Co-Hosts International Women's Day Workshop in Sydney
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
$PFSI Stock Notice: PennyMac Financial Services Stock Plummeted 37% after Refinancing Issues Disclosed – Investors Notified of the Ongoing Securities Fraud Investigation
-
$HUBG Stock Notice: Hub Group Inc. Stock Plummeted 24% after Financial Restatements Disclosed – Investors Notified of the Ongoing Securities Fraud Investigation
-
Man Group PLC : Form 8.3 - LondonMetric Property Plc
-
AL Sydbank A/S share buyback programme: transactions in week 10
-
Man Group PLC : Form 8.3 - Beazley Plc
-
Transactions in connection with share buy-back program
